Barrier-to-autointegration Factor: a First Responder for Repair of Nuclear Ruptures
Overview
Authors
Affiliations
The nuclear envelope (NE) is a critical barrier between the cytosol and nucleus that is key for compartmentalization within the cell and serves an essential role in organizing and protecting genomic DNA. Rupturing of the NE through loss of constitutive NE proteins and/or mechanical force applied to the nucleus results in the unregulated mixing of cytosolic and nuclear compartments, leading to DNA damage and genomic instability. Nuclear rupture has recently gained interest as a mechanism that may participate in various NE-associated diseases as well as cancer. Remarkably, these rupturing events are often transient, with cells being capable of rapidly repairing nuclear ruptures. Recently, we identified Barrier-to-Autointegration Factor (BAF), a DNA-binding protein involved in post-mitotic NE reformation and cytosolic viral regulation, as an essential protein for nuclear rupture repair. During interphase, the highly mobile cytosolic BAF is primed to monitor for a compromised NE by rapidly binding to newly exposed nuclear DNA and subsequently recruiting the factors necessary for NE repair. This review highlights the recent findings of BAF's roles in rupture repair, and offers perspectives on how regulatory factors that control BAF activity may potentially alter the cellular response to nuclear ruptures and how BAF may participate in human disease.
Cancer nuclear envelope rupture and repair in taxane resistance.
Xu A, Xu L, Smith E, Fleishman J, Chen Z, Xu X Med Rev (2021). 2024; 4(6):522-530.
PMID: 39664077 PMC: 11629310. DOI: 10.1515/mr-2024-0019.
Di Bona M, Bakhoum S Front Cell Dev Biol. 2024; 12:1475095.
PMID: 39359718 PMC: 11445188. DOI: 10.3389/fcell.2024.1475095.
Micronuclear collapse from oxidative damage.
Di Bona M, Chen Y, Agustinus A, Mazzagatti A, Duran M, Deyell M Science. 2024; 385(6712):eadj8691.
PMID: 39208110 PMC: 11610459. DOI: 10.1126/science.adj8691.
Di Bona M, Bakhoum S Cancer Discov. 2024; 14(2):214-226.
PMID: 38197599 PMC: 11265298. DOI: 10.1158/2159-8290.CD-23-1073.
Halfmann C, Scott K, Sears R, Roux K bioRxiv. 2024; .
PMID: 38187776 PMC: 10769424. DOI: 10.1101/2023.12.21.572811.